Stay updated on MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial

Sign up to get notified when there's something new on the MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-11T17:44:45.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 replaces the previous Revision: v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-11T05:09:28.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.1, replacing the previous v3.4.0; this is a minor version update and does not affect content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T04:44:28.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI updates include adding a Show glossary option, minor wording/capitalization tweaks to QC criteria and FEAR Act notices (such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and a new revision tag v3.4.0, replacing the previous v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T02:49:37.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    - Footer revision label updated from Revision: v3.3.3 to Revision: v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-14T01:43:39.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Locations were updated: new site entries by state and country (California, Florida, Kansas, Kentucky, Minnesota, New Jersey, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Tennessee, Washington, Ontario, Quebec) were added and corresponding per-location headings were removed, with a revision to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T08:50:01.000Z thumbnail image

Stay in the know with updates to MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MEDI0680 + Durvalumab vs Nivolumab in Advanced Malignancies Clinical Trial page.